QUENTIS THERAPEUTICS
Quentis Therapeutics is a developer of immuno-therapeutics designed to address ER stress in multiple diseases. The company's therapeutics are designed to target ER stress pathways and awaken the immune system's ability to fight cancer, enabling patients to get access to new treatments for cancer.
QUENTIS THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2016-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.quentistx.com
Total Employee:
11+
Status:
Active
Contact:
(646) 440-9249
Email Addresses:
[email protected]
Total Funding:
49 M USD
Technology used in webpage:
SPF Apache Microsoft Exchange Online Office 365 Mail PHP GoDaddy DNS Gravatar Profiles Sectigo SSL Sectigo Domain SSL Unified Layer
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Cerevance
Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.
Comet Therapeutics
Comet Therapeutics is a developer of therapies designed to treat orphan neurological disorders.
Entrada Therapeutics
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Pipeline Therapeutics
Pipeline Therapeutics is a developer of regenerative therapies designed to promote functional recovery of neurological diseases.
scibac
SciBac is a developer of biotherapeutics intended to treat antibiotic diseases.
Tenaya Therapeutics
Tenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.
Twentyeight-Seven Therapeutics
Twentyeight-Seven Therapeutics is a developer of microRNAs designed to target regulatory proteins.
Current Advisors List
Founder
Investors List
New York City Economic Development Corporation - NYCEDC
New York City Economic Development Corporation - NYCEDC investment in Grant - Quentis Therapeutics
Polaris Partners
Polaris Partners investment in Series A - Quentis Therapeutics
Versant Ventures
Versant Ventures investment in Series A - Quentis Therapeutics
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - Quentis Therapeutics
New York Ventures
New York Ventures investment in Series A - Quentis Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Quentis Therapeutics
Taiho Pharmaceutical Co
Taiho Pharmaceutical Co investment in Series A - Quentis Therapeutics
Yonghua Capital
Yonghua Capital investment in Series A - Quentis Therapeutics
Official Site Inspections
http://www.quentistx.com
- Host name: box5634.bluehost.com
- IP address: 162.241.219.101
- Location: Provo United States
- Latitude: 40.2342
- Longitude: -111.6442
- Metro Code: 770
- Timezone: America/Denver
- Postal: 84606
